Dietary Acid Load (DAL), Glycated Hemoglobin A1c (HbA1c), and Metabolic Syndrome (MeS) Mediate the Association of the Adherence to the Dietary Approaches to Stopping Hypertension (DASH)

A Doustmohammadian, SN Saeidlou, S Esfandyari, E Gholizadeh

Published: 07 July 2022

The study aimed to investigate the association of dietary approaches to stop hypertension (DASH) and Mediterranean Diet (MeD) with nonalcoholic fatty liver disease (NAFLD), using structural equation modeling (SEM), among Iranian adults. In this population-based cross-sectional study, 3220 adults (44.65% female), aged ≥18 years, were selected from the Amol Cohort Study (AmolCS). The dietary intakes were assessed by a validated 168-item semi-quantitative food-frequency questionnaire (FFQ). Residual method energy adjustment of MeD and DASH scores were calculated. Demographic characteristics and anthropometric and laboratory measurements were collected. NAFLD was diagnosed by an expert radiologist via ultrasound sonography. Based on the primary hypothesis, DASH, MeD, and NAFLD were fitted in models. Metabolic syndrome (MetS) as a potential risk factor directly affected NAFLD in all these models. In both genders, adherence to DASH negatively affected NAFLD indirectly through the two following paths. 1) Dietary acid load (DAL) and metabolic syndrome 2) DAL and HBA1c. In addition, DAL positively affected NAFLD among male participants indirectly via HBA1c and MeS. Similarly, in both genders, the relationship between MeD and NAFLD was mediated through 1) DAL, HBA1c, and MeS and 2) DAL and MeS. Further, among male participants, the MeD and NAFLD were also associated via the mediators of HBA1c and MeS. In female participants, adherence to MeD directly influenced NAFLD. Read more

Executive Chef Giuseppe Urbano

Executive Chef Giuseppe Urbano is a Certified Executive Chef, clinical culinary innovator, and the founder of Meals For Longevity™ (MFL). Operating out of the Sarasota, Florida area, Chef Giuseppe has dedicated his career to bridging the gap between gourmet culinary arts and evidence-based clinical nutrition.

He is the architect of the MFL Program Framework™ and the proprietary Dual-Track Nutritional System, which allows clients to seamlessly navigate between the authentic Modern Mediterranean Path and a high-protein New American 2025 (DGA) Upgrade, known as The Metabolic Switch™.

Chef Giuseppe’s protocols are meticulously engineered to combat cardio-metabolic diseases sustainably. His culinary frameworks are strictly aligned with the highest global nutritional standards, including the MedDiet 4.0 updates, LARN 2014/2024 guidelines, and the 2025 Dietary Guidelines for Americans. Through his 28-Day Transformation program and clinical recipe development, he empowers individuals to achieve sustainable weight management, cellular health, and long-term metabolic vitality without sacrificing the joy of eating.

https://www.chefgiuseppeurbano.com
Previous
Previous

Adherence to the mediterranean diet improved clinical scores and inflammatory markers in children with active inflammatory bowel disease: A randomized trial